[Cellular and humoral factors of immunogenesis of sytemic lupus erythematosus and systemic scleroderma]. 1973

A A Demin, and V A Galenok, and V V Kolesnuk, and A F Finchenko

UI MeSH Term Description Entries
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007369 Interferon Inducers Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. Inducers, Interferon
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D005260 Female Females
D006386 Hemagglutination Tests Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed) Hemagglutination Test,Test, Hemagglutination,Tests, Hemagglutination

Related Publications

A A Demin, and V A Galenok, and V V Kolesnuk, and A F Finchenko
April 1978, Vestnik dermatologii i venerologii,
A A Demin, and V A Galenok, and V V Kolesnuk, and A F Finchenko
January 1982, Terapevticheskii arkhiv,
A A Demin, and V A Galenok, and V V Kolesnuk, and A F Finchenko
October 1990, The Journal of rheumatology,
A A Demin, and V A Galenok, and V V Kolesnuk, and A F Finchenko
January 1965, Journal of the National Medical Association,
A A Demin, and V A Galenok, and V V Kolesnuk, and A F Finchenko
January 1977, Zhurnal eksperimental'noi i klinicheskoi meditsiny,
A A Demin, and V A Galenok, and V V Kolesnuk, and A F Finchenko
January 1989, Terapevticheskii arkhiv,
A A Demin, and V A Galenok, and V V Kolesnuk, and A F Finchenko
January 1976, Przeglad dermatologiczny,
A A Demin, and V A Galenok, and V V Kolesnuk, and A F Finchenko
August 1989, The Journal of rheumatology,
A A Demin, and V A Galenok, and V V Kolesnuk, and A F Finchenko
September 1993, Current opinion in rheumatology,
A A Demin, and V A Galenok, and V V Kolesnuk, and A F Finchenko
April 1979, The Medical journal of Australia,
Copied contents to your clipboard!